English investment fund seeks to acquire Amoun Pharmaceutical for $600m
Canadian Valeant Pharmaceuticals International has sought exiting Amoun since 2011, sources say
Sales of pharmaceutical companies increase by EGP 10bn, growing by 31%
Factories’ revenues amounted to EGP 5bn in November, despite calls for raising…